United States was Novanta’s largest region in fiscal 2025, bringing in $519.01M of $980.60M (53%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $372.35M | $418.27M | $487.11M | $519.01M | ||||||||||||
| Rest Of Europe | $137.80M | $137.03M | $128.87M | $137.41M | ||||||||||||
| Rest Of Asia-Pacific | $101.60M | $105.35M | $107.05M | $97.03M | ||||||||||||
| Germany | $133.73M | $128.23M | $123.24M | $114.65M | ||||||||||||
| Asia-Pacific | — | — | — | — | ||||||||||||
| Europe | — | — | — | — | ||||||||||||
| China | $97.18M | $73.44M | $84.56M | $93.20M | ||||||||||||
| Japan | — | — | — | — | ||||||||||||
| Other Countries | $18.25M | $19.35M | $18.40M | $19.31M | ||||||||||||
| Other Country | — | — | — | — | ||||||||||||
| Total | $860.90M | $881.66M | $949.25M | $980.60M |
Novanta brought in $980.60M from its six regions in fiscal 2025, the year ended December 31, 2025. That was up 3.3% from $949.25M in fiscal 2024. United States was the largest at $519.01M (52.9%), ahead of Rest Of Europe at $137.41M (14.0%) and Germany at $114.65M (11.7%). The other three regions brought in $209.54M combined.
Compared with fiscal 2024, China grew fastest, up 10.2% to $93.20M, while Rest Of Asia-Pacific fell the most, down 9.4% to $97.03M. From fiscal 2022 to 2025, combined revenue from these regions grew from $860.90M to $980.60M, a compound annual growth rate of 4.4%. United States' share of the total rose from 43.3% to 52.9%.
Robotics & Automation was Novanta’s largest segment in fiscal 2025, bringing in $318.58M of $980.60M (32%).
| Segment | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Robotics & Automation | $308.24M | $273.47M | $288.32M | $318.58M | ||||||||||
| Medical Solutions | — | — | — | — | ||||||||||
| Precision Medicine & Manufacturing | — | — | — | — | ||||||||||
| Advanced Surgery | $182.80M | $203.60M | $208.75M | $242.44M | ||||||||||
| Precision Manufacturing | $225.85M | $225.75M | $202.30M | $182.26M | ||||||||||
| Photonics | — | — | — | — | ||||||||||
| Precision Medicine | $144.02M | $178.84M | $249.87M | $237.32M | ||||||||||
| Vision | — | — | — | — | ||||||||||
| Laser Products | — | — | — | — | ||||||||||
| Precision Motion | — | — | — | — | ||||||||||
| Vision Technologies | — | — | — | — | ||||||||||
| Medical Technologies | — | — | — | — | ||||||||||
| Total | $860.90M | $881.66M | $949.25M | $980.60M |
Novanta brought in $980.60M from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 3.3% from $949.25M in fiscal 2024. Robotics & Automation was the largest at $318.58M (32.5%), ahead of Advanced Surgery at $242.44M (24.7%) and Precision Medicine at $237.32M (24.2%). The remaining segment, Precision Manufacturing, brought in $182.26M.
Compared with fiscal 2024, Advanced Surgery grew fastest, up 16.1% to $242.44M, while Precision Manufacturing fell the most, down 9.9% to $182.26M. From fiscal 2022 to 2025, combined revenue from these segments grew from $860.90M to $980.60M, a compound annual growth rate of 4.4%. Robotics & Automation's share of the total fell from 35.8% to 32.5%.
Automation Enabling Technologies was Novanta’s largest region in fiscal 2025, bringing in $500.84M of $980.60M (51%).
| Contract with customer end market. | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Automation Enabling Technologies | $534.09M | $499.22M | $490.62M | $500.84M |
| Medical Solutions | $326.81M | $382.44M | $458.63M | $479.77M |
| Total | $860.90M | $881.66M | $949.25M | $980.60M |
Novanta brought in $980.60M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 3.3% from $949.25M in fiscal 2024. Automation Enabling Technologies was the largest at $500.84M (51.1%), ahead of Medical Solutions at $479.77M (48.9%).
Compared with fiscal 2024, Medical Solutions grew 4.6% to $479.77M and Automation Enabling Technologies grew 2.1% to $500.84M. From fiscal 2022 to 2025, combined revenue from these regions grew from $860.90M to $980.60M, a compound annual growth rate of 4.4%. Automation Enabling Technologies' share of the total fell from 62.0% to 51.1%.
Novanta (NOVT) reports its revenue by geography, by segment and by contract with customer end market.. In fiscal 2025, United States was its largest region, bringing in $519.01M (52.9% of the total), followed by Rest Of Europe at $137.41M (14.0%).
United States was Novanta's largest region in fiscal 2025, bringing in $519.01M, or 52.9% of the $980.60M total across its six regions.
Robotics & Automation was Novanta's largest segment in fiscal 2025, bringing in $318.58M, or 32.5% of the $980.60M total across its four segments.
Among Novanta's regions that make up at least 2% of revenue, China grew fastest in fiscal 2025, up 10.2% from $84.56M to $93.20M.
Every figure comes from Novanta's annual financial filings, as reported. Each line keeps the name Novanta gives it, and years follow its fiscal calendar.
Novanta's revenue by geography goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.